About Us
Overview
At DSP, we understand that time is money…and we take a proactive, focused approach to all of our studies and services, including study start-up.
DSP executives and support staff come directly from the pharmaceutical and biotech industries, enabling us to better understand your needs and view studies from your perspective: How can we do the study better, faster, and under budget?
We are skilled at identifying and resolving potential study issues early on and strategically allocating resources to ensure project completion on time and on-budget. We always have Plan B in place when studies do not go as anticipated.
At DSP, we have developed proven internal SOPs and QA metrics to ensure that quality systems are in place and rigorously followed during every client's clinical study.
In the past several years we have managed and/or monitored more than 50 Phase I - IV clinical trials in various therapeutic areas and have filed 15 New Drug Applications.
Latest News
- DSP Clinical Research Cites 5 Mistakes Sponsors Make When Choosing a CRO
- Centerwatch Profile: Contract Research Organization
- Darlene Panzitta, President and Founder of DSP Clinical Research, Named Ernst & Young Entrepreneur Of The Year® 2009 Award Finalist
- DSP Clinical Research Named to Inc. 500
- What Drives These Rising Companies?
- Octagon Research Solutions Partners with DSP Clinical Research to Extend Clinical Trial Services